共 86 条
[1]
Vichinsky E.(2008)Oral iron chelators and treatment of iron overload in pediatric patients with chronic anemia Pediatrics 121 1253-1256
[2]
Pathare A.(2010)Deferasirox (Exjade®) significantly improves cardiac T2* in heavily ironoverloaded patients with Ann Hematol 89 405-409
[3]
Taher A.(2006)-thalassemia major Blood 107 3738-3744
[4]
Daar S.(2007)Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis Circulation 115 1876-1884
[5]
Pennell D.J.(2008)A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance Acta Hematol 119 133-141
[6]
Berdoukas V.(2010)Patient reported outcomes of Deferasirox (Exjade ICL670) versus Deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of randomized open label phase II trial Acta Haematol 123 220-225
[7]
Karagiorga M.(2009)Improved treatment satisfaction and convenience with Deferasirox in iron-overloaded patients with Circulation 120 1961-1968
[8]
Pennell D.J.(2010)thalassemia: Results from the ESCALATOR trial Blood 115 2364-2371
[9]
Berdoukas V.(2006)Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major Acta Hematol 115 106-108
[10]
Karagiorga M.(2006)Efficacy of deferasirox in reducing and preventing cardiac iron overload in â-thalassemia J Cardiovasc Magn Reson 8 543-547